Review
Accepted on 03 Mar 2025
Potential target within the tumor microenvironment -MT1-MMP
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1517519
Type at least 3 characters
42,499 articles
Articles
Original Research
Accepted on 03 Mar 2025
Impact of atopic dermatitis on renal dysfunction: Insights from patient data and animal models
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1558596
Review
Accepted on 03 Mar 2025
Current Understanding on Inferior Quality of Liver Grafts by Donation after Circulatory Death based on Multi-omics Data
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1548735
Original Research
Accepted on 03 Mar 2025
Amelioration of aging-induced muscular decline by black soybean (Rhynchosia nulubilis) and black rice (Oryza sativa L.) extracts
in Nutritional Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554941
Original Research
Accepted on 03 Mar 2025
Design of a Peptide-Based Vaccine Against Human Respiratory Syncytial Virus (hRSV) Using a Reverse Vaccinology Approach: Evaluation of Immunogenicity, Antigenicity, Allergenicity, and Toxicity
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546254
Original Research
Accepted on 03 Mar 2025
Preoperative Donor Urinary UDP-Glc as an Independent Risk Factor for Delayed Graft Function
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545280
Review
Accepted on 03 Mar 2025
ETS-1 in Tumor Immunology: Implications for Novel Anti-Cancer Strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1526368
Review
Accepted on 03 Mar 2025
The role of B2M in cancer immunotherapy resistance：Function, resistance mechanism, and reversal strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1512509
Original Research
Accepted on 03 Mar 2025
Celecoxib Prevents Malignant Progression of Smoking-Induced Lung Tumors via Suppression of the COX-2/PGE2 Signaling Pathway in Mice
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557790
Review
Accepted on 03 Mar 2025
Unraveling the Triad of Immunotherapy, Tumor Microenvironment, and Skeletal Muscle Biomechanics in Oncology
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1572821
Original Research
Accepted on 03 Mar 2025
Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544104
Original Research
Accepted on 03 Mar 2025
Combining Interleukin 6 and EBV DNA levels predicts survival outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving chemoimmunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560897
Case Report
Accepted on 03 Mar 2025
Case report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody Camrelizumab combined with chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1539373
Review
Accepted on 03 Mar 2025
Dynamic Regulation of Neutrophil Immunometabolism by Platelet-Derived Metabolites
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542438
Mini Review
Accepted on 03 Mar 2025
Iron and energy metabolic interactions in Treg-mediated immune regulation
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554028
Original Research
Accepted on 03 Mar 2025
Association between blood inflammatory status and the survival of tuberculosis: a five-year cohort study
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556857